ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 09-07-2018
AUM:
₹ 3,834.82 Cr
Expense Ratio
1.95%
Benchmark
S&P BSE Healthcare TRI
ISIN
INF109KC1GG4
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Dharmesh Kakkad, Sharmila D'mello
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option | 53.98 | 15.04 | 24.97 |
| S&P BSE Healthcare TRI | 52.5 | 14.07 | 21.99 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
21.12
Last change
0.02 (0.0947%)
Fund Size (AUM)
₹ 3,834.82 Cr
Performance
20.65% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund Manager
Dharmesh Kakkad, Sharmila D'mello
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 15.16 |
| Divi's Laboratories Ltd. | 7.63 |
| Aurobindo Pharma Ltd. | 6.84 |
| Dr. Reddy's Laboratories Ltd. | 6.45 |
| Apollo Hospitals Enterprise Ltd. | 5.43 |
| Lupin Ltd. | 5.23 |
| Cipla Ltd. | 4.89 |
| Mankind Pharma Ltd. | 3.36 |
| Gland Pharma Ltd. | 3.34 |
| Fortis Healthcare Ltd. | 2.54 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 87.25 |
| Chemicals | 6.42 |
| Insurance | 3.25 |
| Others | 2.28 |
| Services | 0.8 |